Screener
Opko Health OPK Gain Loss On Sale Of Other Assets
Gain Loss On Sale Of Other Assets at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| Line item | For the three months ended June 30, 2026 | For the three months ended June 30, 2025 | For the six months ended June 30, 2026 | For the six months ended June 30, 2025 |
|---|---|---|---|---|
| Selling, general and administrative | 52,924 | 59,597 | 101,531 | 118,683 |
| Research and development | 33,166 | 30,342 | 62,365 | 61,183 |
| Amortization of intangible assets | 18,969 | 19,444 | 37,935 | 39,304 |
| Gain on sale of assets | (18,070) | — | (18,070) | — |
| Total costs and expenses | 170,552 | 216,788 | 345,764 | 433,907 |
| Operating loss | (6,972) | (59,981) | (57,987) | (127,148) |
| Other income (expense), net: | ||||
| Interest income | 3,221 | 3,287 | 6,228 | 7,968 |
Item 1. Financial Statements
FAQ
- What is Opko Health's gain loss on sale of other assets?
- Opko Health (OPK) reported gain loss on sale of other assets of $18.07M in Q2 2026.
- What does gain loss on sale of other assets mean?
- This metric captures the net profit or loss recognized from the divestiture of non-core assets, such as equipment, property, or intellectual property rights. It highlights the impact of capital recycling activities on the company's bottom line outside of standard operating revenue. Investors use this to distinguish between recurring operational performance and one-time gains or losses from asset management.
Ask your AI about Opko Health's gain loss on sale of other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude